ScholarLens Back to search
2022•JAMARequires access

Type of Oral Anticoagulant and Adverse Clinical Outcomes in Patients Extending Anticoagulation Therapy Beyond 90 Days After Hospitalization for VTE

Renin Chang, Chih‐Cheng Lai

Open publisher page 1 citations

Abstract

To the Editor We have several concerns about the recent study1 that demonstrated no significant difference in major bleeding with extended-duration direct oral anticoagulant (DOAC) therapy beyond 90 days after initial discharge for venous thromboembolism (VTE).

About this research paper

What this paper is about

To the Editor We have several concerns about the recent study1 that demonstrated no significant difference in major bleeding with extended-duration direct oral anticoagulant (DOAC) therapy beyond 90 days after initial discharge for venous thromboembolism (VTE).

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

To the Editor We have several concerns about the recent study1 that demonstrated no significant difference in major bleeding with extended-duration direct oral anticoagulant (DOAC) therapy beyond 90 days after initial discharge for venous thromboembolism (VTE).

Key concepts: Medicine, Venous thromboembolism, Oral anticoagulant, Major bleeding, Anticoagulant therapy, Adverse effect, Anticoagulant, Intensive care medicine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Type of Oral Anticoagulant and Adverse Clinical Outcomes in Patients Extending Anticoagulation Therapy Beyond 90 Days After Hospitalization for VTE — Research Paper | ScholarLens